CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- SC 13D/A Stake Beneficial Ownership Report
- 4 Other acquisition 10% owner acquired 228,105 shares (other)
- 8-K Event Other events
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President & CEO gave up 16,346 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 8,724 shares (to pay taxes)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,404 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,308 shares (to pay taxes)
- 4 Open-market buy Director bought 6,250 shares at $8.00 ($50,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CT ORDER Other Confidential Order
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
Page 31 of 33 · 652 filings